J. Bourhis

University Hospital of Lausanne

Papers

1

Total Citations

2

H-Index

1

About

J. Bourhis is a leading figure in radiation oncology, with a research focus on optimizing treatment strategies for head and neck cancers, particularly oropharyngeal, supraglottic, and hypopharyngeal carcinomas. His major contribution lies in pioneering comparative effectiveness research between radiotherapy and trans-oral surgery (TOS) for early-stage disease. The 2022 Phase III study, "Best of" Radiotherapy versus "Best of" Surgery, is a landmark trial that directly addresses the long-standing clinical equipoise between these modalities, aiming to define the optimal approach for T1-T2, N0-N1 tumors. This work has garnered 2 citations, reflecting its emerging influence as a practice-changing investigation. Bourhis’s research is notable for its rigorous methodology and patient-centered outcomes, bridging the gap between surgical and radiation disciplines. His achievements include shaping clinical guidelines and fostering multidisciplinary collaboration, making him a key voice in head and neck oncology. For students and researchers, Bourhis exemplifies how comparative trials can resolve therapeutic dilemmas and improve patient care.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
706TiP Phase III study assessing the “best of” radiotherapy compared to the “best of” surgery (trans-oral surgery (TOS)) in patients with T1-T2, N0-N1 oropharyngeal, supraglottic carcinoma and with T1, N0 hypopharyngeal carcinoma
2 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 18
🏛 Institutions: University Hospital of Lausanne

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago